Neuren Pharmaceuticals (ASX:NEU) Other Stockholders Equity : A$-0.0 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Neuren Pharmaceuticals Other Stockholders Equity?

Neuren Pharmaceuticals's Other Stockholders Equity for the quarter that ended in Dec. 2023 was A$-0.0 Mil.

Neuren Pharmaceuticals's quarterly Other Stockholders Equity increased from Dec. 2022 (A$-0.0 Mil) to Jun. 2023 (A$0.0 Mil) but then declined from Jun. 2023 (A$0.0 Mil) to Dec. 2023 (A$-0.0 Mil).

Neuren Pharmaceuticals's annual Other Stockholders Equity declined from Dec. 2021 (A$-0.0 Mil) to Dec. 2022 (A$-0.0 Mil) and declined from Dec. 2022 (A$-0.0 Mil) to Dec. 2023 (A$-0.0 Mil).

Neuren Pharmaceuticals Other Stockholders Equity Historical Data

The historical data trend for Neuren Pharmaceuticals's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuren Pharmaceuticals Other Stockholders Equity Chart

Neuren Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

Neuren Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	-	-	-

Neuren Pharmaceuticals Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Neuren Pharmaceuticals Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Neuren Pharmaceuticals's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuren Pharmaceuticals (ASX:NEU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuren Pharmaceuticals Ltd (ASX:NEU) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

NURPF:USA

Address

697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.neurenpharma.com

Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome.